Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003), a leading Chinese provider of cardiovascular disease solutions, has received marketing approval from the National Medical Products Administration (NMPA) for its self-developed coronary mastoid balloon dilation catheter. The device, classified as a Category III medical device, is indicated for balloon dilation in patients with coronary artery stenosis and ischemia.
The coronary mastoid balloon dilation catheter plays a crucial role in dilating the narrowed sections of the coronary artery. Characterized by its surface pattern of papillary protrusions, this catheter is designed to fracture hard plaques during high-pressure dilation. The protrusions remain stable, preventing the device from slipping. Post-stent placement, the mastoid balloon’s unique structure ensures excellent stent adhesion to the arterial wall, enhancing the overall treatment efficacy.- Flcube.com
